Key facts
- It has raised $1.2M across 1 recorded rounds; the latest was Seed Round ($270K) in May 2025.
- Notable investors include Charles Barkley, William Clayton.
- NeuroVice has filed 1 Form D with the SEC, most recently Jun 2025 ($270K sold to 5 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for NeuroVice
Funding rounds
1 roundsAbout NeuroVice
Manufacturer of a medical device intended to protect the tongue during seizures. The company's product is a structural and functional instrument that prevents the patient from biting and/or injuring their tongue and from hypersalivation, which can lead to foaming at the mouth, enabling users to get enhanced safety during neurological episodes.
- Sector
- Healthcare
- HQ
- Cary, NC, United States
- Founded
- 2016
- Employees
- 3
- Website
- usepati.com/
- Ownership
- Privately Held (backing)
NeuroVice doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroVice shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroVice in its N-PORT filings yet. We sweep new filings monthly.